Advertisement
Screener

SHOULDER INNOVATIONS, INC. (SI) Graph

3.6 / 5 stars · 5/7 Roast Me

Add as a preferred source on Google

SI Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $17.18M; Cost of revenue $3.73M; Research and development $3.39M; Selling, general and administrative $20.09M.
  • 2026-03-31: Revenue $16.71M; Cost of revenue $3.72M; Research and development $3.75M; Selling, general and administrative $18.21M.
  • 2025-12-31: Revenue $14.42M*; Cost of revenue $3.36M*; Research and development $3.22M*; Selling, general and administrative $16.34M*.
  • 2025-09-30: Revenue $11.76M; Cost of revenue $2.79M; Research and development $1.52M; Selling, general and administrative $15.08M.

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

SI revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment$17.18MRevenue$17.18MCost of revenue$3.73MGross profit$13.44MOperating income-$10.04MOther income, net-$201.00KResearch & development$3.39MSelling, general& administrative$20.09MPre-tax income-$10.15MIncome tax$0.00Net income-$10.15M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$17.18M$3.73M$3.39M$20.09M$0.00-$10.15M
2026-03-31$16.71M$3.72M$3.75M$18.21M$0.00-$8.38M
2025-12-31$14.42M*$3.36M*$3.22M*$16.34M*$0.00*-$7.77M*
2025-09-30$11.76M$2.79M$1.52M$15.08M$0.00-$8.73M
2025-06-30$11.01M$2.62M$1.41M$12.85M$0.00-$19.20M
2025-03-31$10.13M$2.34M$1.58M$10.50M$0.00-$4.66M
2024-09-30$7.45M$1.75M$1.09M$8.49M$0.00-$4.05M
2024-06-30$8.26M$1.91M$1.16M$9.17M$0.00-$4.17M
2024-03-31(m)(m)(m)(m)(m)-$3.60M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$33.88M$7.46M$7.14M$38.29M$0.00-$18.53M
2025-06-30$21.14M$4.96M$2.99M$23.35M$0.00-$23.86M
2024-06-30$15.44M$3.57M$2.23M$16.88M$0.00-$7.77M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-30$32.90M$7.76M$4.51M$38.43M$0.00-$32.59M
2024-09-30$22.90M$5.33M$3.32M$25.37M$0.00-$11.83M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-31$47.32M$11.12M$7.73M$54.77M$0.00-$40.36M
2024-12-31$31.62M$7.28M$4.49M$34.51M$0.00-$15.62M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
Orthofix Medical Inc. (OFIX)$0.373B
Embecta Corp. (EMBC)United States$0.319B2.10
CARLSMED, INC. (CARL)United States$0.405B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Advertisement